Web Analytics

3 Latest Announced Rounds

$312.57M Raised in 34 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Ochre Bio

start up
United Kingdom - Oxford
  • 11/10/2022
  • Series A
  • $30,000,000

Ochre Bio develops RNA therapies for chronic liver diseases, a leading cause of death globally.

Privately held, Ochre Bio is situated within the heart of Oxford’s biotech innovation hub. To learn more, please visit www.ochre-bio.com.


Related People

Jack O'MearaCo Founder

Jack O'Meara United Kingdom - Oxford, England,

I help to get new medicines and healthcare technologies to patients.

Interested in the intersection of science, medicine, and business.